Document Detail

Microarray evaluation of specific IgE to allergen components in elite athletes.
MedLine Citation:
PMID:  23033844     Owner:  NLM     Status:  Publisher    
BACKGROUND: Allergic sensitization and diseases have been reported to have a very high and increasing prevalence in elite athletes. Over 80% of allergic athletes are poly-sensitized. OBJECTIVE: This study aims at evaluating the potential diagnostic added value of a microarray technology (ImmunoCAP ISAC, Phadia AB [at present Thermo Fisher Scientific] Uppsala, Sweden which detects IgE antibodies to specific or cross-reacting allergen components. METHODS: Seventy-two poly-sensitized athletes according to skin prick test (SPT) with different allergic phenotypes (asthma n = 19; rhino-conjunctivitis n = 20; food allergy and/or oral allergy syndrome n = 13; no clinical symptoms n = 20) and two different control populations (20 poly-sensitized sedentary subjects with respiratory allergy and 20 healthy athletes with negative SPT) were studied for detecting specific IgE (sIgE) both to allergen extracts (ImmunoCAPsIgE) and to allergen components (ImmunoCAP ISAC). RESULTS: ImmunoCAP ISAC detected the presence of sIgE in 90% of poly-sensitized athletes - in 96% with symptoms and in 75% without symptoms - and in 100% of allergic controls. The pattern of positivity towards the 103 components tested differed from subject to subject, even in those with the same sensitization to allergen extract SPT or sIgE. Based on the ISAC results, poly-sensitized athletes were classified into the following prototypical patterns, differently represented in the clinical phenotypes studied (P = 0.03): (1) One single predominant specific allergen positivity; (2) sIgE to two or more non-cross-reacting allergens; (3) sIgE to cross-reacting allergens; and (4) sIgE to components potentially responsible for severe allergic reactions. CONCLUSIONS: The ImmunoCAP ISAC represents a useful additional tool for diagnosis and management of poly-sensitized athletes.
M Bonini; L Marcomini; C Gramiccioni; C Tranquilli; G Melioli; G W Canonica; S Bonini;
Related Documents :
9276524 - Human mast cells expressing recombinant proteinase 3 (pr3) as substrate for clinical te...
4035734 - Elisa using intact promastigotes for immunodiagnosis of kala-azar.
24759554 - A new reliable method for detecting specific ige antibodies in the patients with immedi...
16317444 - Serological survey of pre-weaned new zealand fur seals (arctocephalus forsteri) for bru...
10897454 - Cuttlebone morphology limits habitat depth in eleven species of sepia (cephalopoda: sep...
8703524 - Pilot study of the acceptability of cystic fibrosis carrier testing during routine ante...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-4
Journal Detail:
Title:  Allergy     Volume:  -     ISSN:  1398-9995     ISO Abbreviation:  Allergy     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7804028     Medline TA:  Allergy     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy; Department of Medicine, "Sapienza" University, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A scalable method for identifying frequent subtrees in sets of large phylogenetic trees.
Next Document:  A Novel Splice-Site Mutation in ATP8B1 Results in Atypical Progressive Familial Intrahepatic Cholest...